Gene-based therapeutics for rare genetic neurodevelopmental psychiatric disorders

We are in an emerging era of gene-based therapeutics with significant promise for rare genetic disorders. The potential is particularly significant for genetic central nervous system disorders that have begun to achieve Food and Drug Administration approval for select patient populations. This review summarizes the discussions and presentations of the National Institute of Mental Health-sponsored workshop Gene-Based Therapeutics for Rare Genetic Neurodevelopmental Psychiatric Disorders, which was held in January 2021. Here, we distill the points raised regarding various precision medicine approaches related to neurodevelopmental and psychiatric disorders that may be amenable to gene-based therapies.

Automated summary

The review summarizes the discussions and presentations of a workshop sponsored by the National Institute of Mental Health, focusing on gene-based therapeutics for rare genetic neurodevelopmental psychiatric disorders. It highlights the potential of precision medicine approaches in treating these disorders.